Skip to content
OpenCapital
Get started

Indaptus Therapeutics, Inc. INDP Q4 2024 Annual earnings

Reported March 13, 2025 · Before market open

Diluted EPS-$0.38Beat by $0.03
EPS estimate-$0.41

Next report

Aug 17, 2026 (in a month)
EPS estimate-$1.57

Versus estimates

Diluted EPS

Q1 2026-$0.23Beat by $1.64Q4 2025-$3.10Beat by $1.26Q3 2025-$2.98Beat by $1.19Q2 2025-$9.09Beat by $0.15Q1 2025-$8.96Beat by $2.52
Q4 2024-$0.38Beat by $0.03

Ask the moment Indaptus Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Indaptus Therapeutics, Inc. report Q4 2024 earnings?
Indaptus Therapeutics, Inc. (INDP) reported Q4 2024 earnings on March 13, 2025 before market open.
What were Indaptus Therapeutics, Inc.'s Q4 2024 revenue and EPS?
Indaptus Therapeutics, Inc. reported diluted EPS of $-0.38 for Q4 2024.
Did Indaptus Therapeutics, Inc. beat estimates in Q4 2024?
EPS beat the consensus estimate of $-0.41 by $0.03.
Where can I find Indaptus Therapeutics, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001493152-25-010136) directly on SEC EDGAR. The filing index links above go to sec.gov.